Literature DB >> 25077578

Prolonged febrile illness and fever of unknown origin in adults.

Elizabeth C Hersch1, Robert C Oh2.   

Abstract

Fever of unknown origin has been described as a febrile illness (temperature of 101°F [38.3°C] or higher) for three weeks or longer without an etiology despite a one-week inpatient evaluation. A more recent qualitative definition requires only a reasonable diagnostic evaluation. Although there are more than 200 diseases in the differential diagnosis, most cases in adults are limited to several dozen possible causes. Fever of unknown origin is more often an atypical presentation of a common disease rather than an unusual disease. The most common subgroups in the differential are infection, malignancy, noninfectious inflammatory diseases, and miscellaneous. Clinicians should perform a comprehensive history and examination to look for potentially diagnostic clues to guide the initial evaluation. If there are no potentially diagnostic clues, the patient should undergo a minimum diagnostic workup, including a complete blood count, chest radiography, urinalysis and culture, electrolyte panel, liver enzymes, erythrocyte sedimentation rate, and C-reactive protein level testing. Further testing should include blood cultures, lactate dehydrogenase, creatine kinase, rheumatoid factor, and antinuclear antibodies. Human immunodeficiency virus and appropriate region-specific serologic testing (e.g., cytomegalovirus, Epstein-Barr virus, tuberculosis) and abdominal and pelvic ultrasonography or computed tomography are commonly performed. If the diagnosis remains elusive, 18F fluorodeoxyglucose positron emission tomography plus computed tomography may help guide the clinician toward tissue biopsy. Empiric antibiotics or steroids are generally discouraged in patients with fever of unknown origin.

Entities:  

Mesh:

Year:  2014        PMID: 25077578

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  7 in total

1.  Pneumocystis jirovecii pneumonia presenting as a solitary pulmonary granuloma due to unclean continuous positive airway pressure equipment: a case report.

Authors:  Lun-Yu Jao; Wen-Lin Su; Hsu-Chao Chang; Chou-Chin Lan; Yao-Kuang Wu; Mei-Chen Yang
Journal:  J Clin Sleep Med       Date:  2022-06-01       Impact factor: 4.324

2.  Comparison of classical diagnostic criteria and Chinese revised diagnostic criteria for fever of unknown origin in Chinese patients.

Authors:  Jia-Jun Li; Wen-Xiang Huang; Zheng-Yu Shi; Qiu Sun; Xiao-Juan Xin; Jin-Qiu Zhao; Zhen Yin
Journal:  Ther Clin Risk Manag       Date:  2016-10-12       Impact factor: 2.423

3.  Primary percutaneous coronary intervention during ST elevation myocardial infarction in prosthetic valve endocarditis: a case report.

Authors:  Alfonso Campanile; Guido Tavazzi; Francesco Caprioglio; Fausto Rigo
Journal:  BMC Cardiovasc Disord       Date:  2018-02-09       Impact factor: 2.298

4.  Mycoplasma Pneumonia: An Unrecognized Cause of Fever of Unknown Origin in an Adult.

Authors:  Fatima Ali-Ahmed; Alexandra Halalau
Journal:  Case Rep Infect Dis       Date:  2017-10-17

5.  Lack of Clinical Utility of Labeled White Blood Cell Scintigraphy in Patients With Fever of Unknown Origin.

Authors:  Ronald E Fisher; Ashley L Drews; Edwin L Palmer
Journal:  Open Forum Infect Dis       Date:  2022-01-11       Impact factor: 3.835

6.  Fever of Unknown Origin: The Workup and Diagnosis of Pel-Ebstein Fever.

Authors:  Prachi Khanna; Natalie Malluru; Raaj Pyada; Mitul Gupta; Kartik Akkihal; Thomas C Varkey
Journal:  Cureus       Date:  2022-02-06

7.  Key diagnostic characteristics of fever of unknown origin in Japanese patients: a prospective multicentre study.

Authors:  Toshio Naito; Mika Tanei; Nobuhiro Ikeda; Toshihiro Ishii; Tomio Suzuki; Hiroyuki Morita; Sho Yamasaki; Jun'ichi Tamura; Kenichiro Akazawa; Koji Yamamoto; Hiroshi Otani; Satoshi Suzuki; Motoo Kikuchi; Shiro Ono; Hiroyuki Kobayashi; Hozuka Akita; Susumu Tazuma; Jun Hayashi
Journal:  BMJ Open       Date:  2019-11-19       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.